Raltegravir EP Impurity G

Raltegravir EP Impurity G is a structurally related degradation byproduct arising from oxidative stress pathways of the parent antiretroviral agent Raltegravir. It retains the core 1,2,4-triazole-1-ylmethyl linkage but exhibits a cleaved cyclopropylmethyl side chain replaced by a carboxylic acid terminus, resulting in altered hydrogen bonding capacity and reduced lipophilicity. The compound features a naphthyridine heterocycle with preserved 5-methyl substitution, maintaining key π-electron conjugation for chromatographic differentiation. This impurity serves as a critical HPLC reference standard for quantifying oxidative degradation in Raltegravir formulations under ICH stability protocols.